MAIA Biotechnology financial statements
마이어 바이오테크놀로지NYSEAMERICAN:MAIA · NYSE Amex · Healthcare · sector #13$1.18-0.84%
2026-10-05 closeMAIA Biotechnology's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$17M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy